1/Fantastic talk by @CharuAggarwalMD on molecular/biomarker testing & data. Why is it important? Targeted therapy improves outcomes, IO does not work for everyone & IO b4 TKIs has been associated w/severe AEs in some patients #COA2020 #LCSM @EGFRResisters

2/ @CharuAggarwalMD talks which markers to test for & her must-have, good to have and nice to have molecular markers & guidelines for testing, including NGS vs sequential testing = NGS more cost-effective & time to results is faster #COA2020 #LCSM

3/Use of plasma-based NGS to fully realize benefit of precision medicine in initial dx & therapy selection, monitoring of resistance & tumor heterogeneity. And identifying more patients with the addition of plasma NGS compared to tissue alone. #COA2020 #LCSM

4/The importance of getting a tissue biopsy if a patient has a neg plasma-based NGS test (low shedder?), findings of interest, key takeaways of liquid biopsies/plasma-based tests & summary of recommendations, barriers & tips for molecular/biomarker testing. #LCSM #COA2020